Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Robert Nussbaum, Jonathan Berg, Charis Eng, Brynn Levy, Elaine Lyon, and more

Premium

Complete Genomics has formed a genomic medicine advisory board to "provide insight and guidance on the best ways for the company to provide sequencing services to healthcare organizations and physicians interested in implementing genomic medicine in their practice."

Robert Nussbaum, chief of the division of medical genetics in the department of medicine at the University of California, San Francisco, will serve as chairman of the advisory board.

Other founding members include:

Jonathan Berg, assistant professor in the department of genetics at the University of North Carolina, Chapel Hill;

Charis Eng, chair and director of the Genomic Medicine Institute at the Cleveland Clinic and professor and vice chair of the department of genetics at Case Western Reserve University School of Medicine;

Brynn Levy, co-director of the division of personalized genomic medicine at the College of Physicians and Surgeons of Columbia University and director of the clinical cytogenetics laboratory at New York Presbyterian Hospital at Columbia University Medical Center;

Elaine Lyon, associate professor of pathology at the University of Utah School of Medicine and medical director of the genetics division, and co-medical director of pharmacogenomics at Arup Laboratories;

Federico Monzon, associate professor of pathology and immunology and director of molecular pathology at Baylor College of Medicine's Cancer Genetics Laboratory;

DesiRae Muirhead, assistant professor of pathology at Sanford School of Medicine;

Stirling Puck, former vice president for medical affairs at Genzyme Genetics; and

Heidi Rehm, director of the Laboratory for Molecular Medicine at Partners HealthCare Center for Personalized Genetic Medicine and assistant professor of pathology at Harvard Medical School.


The Jackson Laboratory has hired Yijun Ruan for its new center for genomic medicine at the University of Connecticut Health Center in Farmington.

Ruan is currently associate director of the Genome Institute of Singapore and a biochemistry professor at the National University of Singapore.

Ruan will bring up to six members of his research team to the Jackson lab's Connecticut facility. Ruan holds a PhD in plant molecular biology from the University of Maryland, and an MS and BS in microbiology from Huazhong Agricultural University in Wuhan, China.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.